BusinessHemispherx Biopharma to Present Data on the Activity of Ampligen® Against Cancer at CHI’s 4th Annual Immuno-Oncology Summit, August 29 through September 2, 2016 in Boston, MABy Nasdaq OMXAug 29, 2016, 12:30 PM UTC
